Analgesic Efficacy of an Intermediate Cervical Plexus Block in Patients Undergoing Neck Surgeries. A Comparison Between Two Bupivacaine Concentrations.

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study aims to investigate the analgesic efficacy of Intermediate Cervical Plexus Block combined with GA using two bupivacaine concentrations in patients undergoing neck surgeries (total thyroidectomy or total laryngectomy)

Eligibility
Participation Requirements
Sex: All
Minimum Age: 40
Maximum Age: 70
Healthy Volunteers: f
View:

• Any patient aged ≥ 40 years

• ASA physical status I-III scheduled for total thyroidectomy or total laryngectomy under GA.

Locations
Other Locations
Egypt
Cairo university Hospitals. kasralainy
RECRUITING
Cairo
Contact Information
Primary
Nagy malak
nagymalak@kasralainy.edu.eg
01552480258
Backup
Nagy malak
nagymalak12345@gmail.com
01552480258
Time Frame
Start Date: 2023-03-05
Estimated Completion Date: 2024-06-01
Participants
Target number of participants: 54
Treatments
Experimental: Group H
The patient's head was rested on a pillow and turned to the opposite side. A linear probe with higher frequencies was placed transversely over the midpoint of the SCM muscle. The carotid artery was identified and traced upwards to its bifurcation. Probe was then moved laterally to identify the tapering posterolateral end of the SCM muscle. Via an in-plane technique, a 22-gauge, 50 mm needle was advanced underneath the investing fascia of SCM muscle and above the interscalene groove until the pop on piercing the investing fascia was felt. Group H received 20 ml 0.25 % bupivacaine
Active_comparator: Group L received 20 ml 0.125% bupivacaine
The patient's head was rested on a pillow and turned to the opposite side. A linear probe with higher frequencies was placed transversely over the midpoint of the SCM muscle. The carotid artery was identified and traced upwards to its bifurcation. Probe was then moved laterally to identify the tapering posterolateral end of the SCM muscle. Via an in-plane technique, a 22-gauge, 50 mm needle was advanced underneath the investing fascia of SCM muscle and above the interscalene groove until the pop on piercing the investing fascia was felt. Group L received 20 ml 0.125% bupivacaine.
Related Therapeutic Areas
Sponsors
Leads: Cairo University

This content was sourced from clinicaltrials.gov